K F Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-11-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.61 Cr
as on 17-11-2024
- Satisfied Charges ₹ 9.75 Cr
as on 17-11-2024
- Revenue 1.47%
(FY 2023)
- Profit -62.67%
(FY 2023)
- Ebitda -26.47%
(FY 2023)
- Net Worth 6.50%
(FY 2023)
- Total Assets 10.72%
(FY 2023)
About K F Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹9.61 Cr. The company has closed loans amounting to ₹9.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Imaan Sahota and Sangram Sahota serve as directors at the Company.
- CIN/LLPIN
U01119PB2004PTC027531
- Company No.
027531
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationJalandhar, Punjab
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at K F Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Imaan Sahota  | Director | 03-Feb-2020 | Current |
| Sangram Sahota | Director | 03-Feb-2020 | Current |
Financial Performance of K F Biotech.
K F Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.47% increase. The company also saw a substantial fall in profitability, with a 62.67% decrease in profit. The company's net worth moved up by a moderate rise of 6.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of K F Biotech?
In 2023, K F Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- K F Freshlife Farms Private LimitedActive 16 years 7 months
Imaan Sahota and Sangram Sahota are mutual person
- Nandi Cold Storages Private LimitedActive 33 years 1 month
Imaan Sahota and Sangram Sahota are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Jul 2023 | ₹1.07 M | Open |
Hdfc Bank Limited Creation Date: 08 Aug 2022 | ₹3.50 M | Open |
Hdfc Bank Limited Creation Date: 21 Sep 2021 | ₹1.50 M | Open |
How Many Employees Work at K F Biotech?
K F Biotech has a workforce of 32 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K F Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K F Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
